# FDA Inspection 1031323 - BioLIfe Plasma Services L.P. - October 12, 2017

Source: https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/712e3e4e-8ee9-4c00-8d38-75869a137ff4
Source feed: FDA_Inspections

> FDA Inspection 1031323 for BioLIfe Plasma Services L.P. on October 12, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031323
- Company Name: BioLIfe Plasma Services L.P.
- Inspection Date: 2017-10-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1122260 - 2020-01-15](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/ff1ba1cb-b51d-4c0d-83fa-831a68c27660)
- [FDA Inspection 938634 - 2015-08-14](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/80cac399-adce-4835-b061-4a1a2dbfc03a)
- [FDA Inspection 915796 - 2014-09-22](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/3133f91f-9000-4dd8-a68b-2942ac412d9c)

Company: https://www.keypedia.com/companies/biolife-plasma-services-lp/9af020e4-8e6f-4ccb-b90e-35aefee1b2f2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d